In recent decades, the sub-specialization of “clinical suicidology” emphasizing suicide risk assessment, treatment, training, and the management of suicide-related liability has grown exponentially. This line of thinking had led to the development of suicide-specific treatments that target suicide as the focus of care (vs. a primary focus on treating mental disorders). These treatments are being extensively investigated using randomized controlled clinical trials to prove their efficacy and effectiveness. This article features the three main replicated treatments for suicide: Dialectical Behavior Therapy, Cognitive Therapy for Suicide Prevention, and the Collaborative Assessment and Management of Suicidality. In addition, there is a recent surge of brief suicide-focused interventions (1–4 sessions) that include variations of stabilization planning and close examination of suicide attempts as an opportunity to learn about suicidal risk with coping-oriented guidance and support. Within a rapidly evolving contemporary mental health care reality, these suicide-related treatments and interventions hold great promise for the prospect of providing more effective (and potentially life-saving care) for suicidal patients.
This randomized controlled trial compared the Collaborative Assessment and Management of Suicidality (CAMS) and Treatment as Usual (TAU) for suicidal college students within a feasibility trial. Sixty-two suicidal college students were randomized to CAMS (n = 33) or TAU (n = 29). We hypothesized that those receiving CAMS would show more improvement in suicide-related measures, and effects would be moderated by borderline personality disorder (BPD), prior suicide attempts, and age. Both treatment groups showed improvements in all outcome variables; CAMS had a significantly higher impact on depression and suicidal ideation when measured weekly during care and was more likely than TAU to decrease hopelessness among students with fewer BPD features, no suicide attempt history, and older age. Conversely, TAU did better for students with BPD features and history of multiple suicide attempts.
This pilot study investigated the potential to utilize adaptive treatment strategies for treating moderate to severe suicidal risk among college students. This article will describe the unique study design and report on feasibility and acceptability findings. A 2-stage Sequential Multiple Assignment Randomized Trial (SMART) was conducted: In Stage 1, 62 suicidal college students were randomized to either a suicide-focused or a treatment-as-usual condition (4–8 weeks). Those deemed insufficient responders were re-randomized to one of two Stage 2 interventions—both suicide-focused but one comprehensive and multimodal and the other flexible and theoretically agnostic (4–16 additional weeks). Recruitment rates were high, treatment dropout levels were lower than expected for the setting, study dropouts were rare, and counselors were able to deliver suicide-focused approaches with fidelity. Treatment satisfaction was high among clients and moderately high among counselors. Findings from this pilot show that a SMART is highly feasible and acceptable to suicidal college students, counselors, and campuses.
Youths in rural areas have approximately double the risk for suicide than do urban youth. This study analyzed data from 580 youth aged 10 to 17-years-old who endorsed lifetime suicidal ideation on intake at three large rural behavioral health centers. Results indicated that a five-factor model including older age, number of inpatient hospitalizations, gender (female), impaired legal functioning, and higher impulsivity accounted for the most variance in differentiation between ideators and attempters. These results advance our assessment of rural youth who may be at increased risk for a suicide attempt.
Women are visually depicted with lower facial prominence than men, with consequences for perceptions of their competence. The current study examines the relationship between the size of this “face-ism” bias (i.e., individual or micro-level sexism) and a number of gender inequality indicators (i.e., institutional or macro-level sexism) at the cross-cultural level. In one of the largest known face-ism databases to date, the authors used politicians’ official online photographs as stimuli (N = 6,610) to explore how face-ism (as an example of individual-level sexism) covaries with institutional sexism across 25 cultures. The authors found that the face-ism bias was greater in cultures with lower levels of institutional gender inequality, demonstrating that institutional equality does not necessarily imply equality on the individual level. The authors offer a number of potential speculations for this mismatch. For example, it may be due to “postfeminist” backlash that occurs in response to decreases in level of institutional sexism or it may be due to different comparative processes that occur in more versus less gender-equal cultures. Implications for female politicians cross-culturally are discussed. The findings of our study provide empirical evidence to demonstrate how macro-level structural equalities could be related to individual and micro-level sexism, and how different levels of sexism might not necessarily be indicative of each other. Additional online materials for this article are available to PWQ subscribers on PWQ's website at http://pwq.sagepub.com/supplemental.